These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
109 related articles for article (PubMed ID: 20799847)
21. A next-generation bifunctional photosensitizer with improved water-solubility for photodynamic therapy and diagnosis. Nishie H; Kataoka H; Yano S; Kikuchi JI; Hayashi N; Narumi A; Nomoto A; Kubota E; Joh T Oncotarget; 2016 Nov; 7(45):74259-74268. PubMed ID: 27708235 [TBL] [Abstract][Full Text] [Related]
22. Correlation of in vivo photosensitizer fluorescence and photodynamic-therapy-induced depth of necrosis in a murine tumor model. Cheung R; Solonenko M; Busch TM; Del Piero F; Putt ME; Hahn SM; Yodh AG J Biomed Opt; 2003 Apr; 8(2):248-52. PubMed ID: 12683850 [TBL] [Abstract][Full Text] [Related]
23. Studies of the photosensitizer disulfonated meso-tetraphenyl chlorin in an orthotopic rat bladder tumor model. Baglo Y; Peng Q; Hagen L; Berg K; Høgset A; Drabløs F; Gederaas OA Photodiagnosis Photodyn Ther; 2015 Mar; 12(1):58-66. PubMed ID: 25575731 [TBL] [Abstract][Full Text] [Related]
25. Measurement of Cyanine Dye Photobleaching in Photosensitizer Cyanine Dye Conjugates Could Help in Optimizing Light Dosimetry for Improved Photodynamic Therapy of Cancer. James NS; Cheruku RR; Missert JR; Sunar U; Pandey RK Molecules; 2018 Jul; 23(8):. PubMed ID: 30042350 [TBL] [Abstract][Full Text] [Related]
26. In vitro and in vivo antitumor activity of a novel chlorin derivative for photodynamic therapy. Zhang CY; Zhang LJ; Li JW; Li JH; Wu ZM; Zhang LX; Chen N; Yan YJ; Chen ZL Neoplasma; 2016; 63(1):37-43. PubMed ID: 26639232 [TBL] [Abstract][Full Text] [Related]
27. Monitoring the accumulation and dissipation of the photosensitizer protoporphyrin IX during standard dermatological methyl-aminolevulinate photodynamic therapy utilizing non-invasive fluorescence imaging and quantification. Tyrrell J; Campbell SM; Curnow A Photodiagnosis Photodyn Ther; 2011 Mar; 8(1):30-8. PubMed ID: 21333932 [TBL] [Abstract][Full Text] [Related]
28. Improved pharmacokinetics, biodistribution and necrosis in vivo using a new near infra-red photosensitizer: tetrahydroporphyrin tetratosylat. Schastak S; Jean B; Handzel R; Kostenich G; Hermann R; Sack U; Orenstein A; Wang YS; Wiedemann P J Photochem Photobiol B; 2005 Mar; 78(3):203-13. PubMed ID: 15708517 [TBL] [Abstract][Full Text] [Related]
29. Non-homogeneous liver distribution of photosensitizer and its consequence for photodynamic therapy outcome. Vollet-Filho JD; Caracanhas MA; Grecco C; Ferreira J; Kurachi C; Bagnato VS Photodiagnosis Photodyn Ther; 2010 Sep; 7(3):189-200. PubMed ID: 20728844 [TBL] [Abstract][Full Text] [Related]
30. Biodistribution and pharmacokinetic studies of a porphyrin dimer photosensitizer (Oxdime) by fluorescence imaging and spectroscopy in mice bearing xenograft tumors. Khurana M; Ulrich S; Kim A; Moriyama Y; Netchev G; Akens MK; Anderson HL; Wilson BC Photochem Photobiol; 2012; 88(6):1531-8. PubMed ID: 22724520 [TBL] [Abstract][Full Text] [Related]
31. [Fluorescence detection of chlorine E6 based photosensitizer in urinary bladder tumors]. Iagudaev DM; Bulgakova NN; Sorokatyĭ AE; Geĭnits AV; Martov AG Urologiia; 2007; (2):53-6, 58. PubMed ID: 17578199 [TBL] [Abstract][Full Text] [Related]
32. Lymphotropic administration of photosensitizer as a model of target therapy of testicle inflammation: Experimental and clinical data. Yagudaev DM; Brechov EI; Saidov AC; Kalyagina NA; Kuznetsova JO; Loschenov VB Photodiagnosis Photodyn Ther; 2016 Mar; 13():15-21. PubMed ID: 26691323 [TBL] [Abstract][Full Text] [Related]
33. Determination of the maximal carcinoma/normal skin ratio after HpD or m-THPC administration in Hairless mice (SKH-1) by fluorescence spectroscopy. Bossu E; Padilla-Ybarra JJ; Notter D; Vigneron C; Guillemin F Anticancer Drugs; 2000 Feb; 11(2):85-91. PubMed ID: 10789590 [TBL] [Abstract][Full Text] [Related]
34. Fluorescence of radiation-induced tissue damage. Raznitsyna I; Kulikova P; Rogatkin D; Kulikov D; Bychenkov O; Chursinova Y; Bobrov M; Glazkov A Int J Radiat Biol; 2018 Feb; 94(2):166-173. PubMed ID: 29297727 [TBL] [Abstract][Full Text] [Related]
35. Multimodality agents for tumor imaging (PET, fluorescence) and photodynamic therapy. A possible "see and treat" approach. Pandey SK; Gryshuk AL; Sajjad M; Zheng X; Chen Y; Abouzeid MM; Morgan J; Charamisinau I; Nabi HA; Oseroff A; Pandey RK J Med Chem; 2005 Oct; 48(20):6286-95. PubMed ID: 16190755 [TBL] [Abstract][Full Text] [Related]
36. Pharmacokinetic and biodistribution study following systemic administration of Fospeg®--a Pegylated liposomal mTHPC formulation in a murine model. Xie H; Svenmarker P; Axelsson J; Gräfe S; Kyriazi M; Bendsoe N; Andersson-Engels S; Svanberg K J Biophotonics; 2015 Jan; 8(1-2):142-52. PubMed ID: 24375973 [TBL] [Abstract][Full Text] [Related]
37. Depth-resolved imaging of photosensitizer in the rodent brain using fluorescence laminar optical tomography. Gaitan B; Inglut CT; Liu Y; Chen Y; Huang HC J Biomed Opt; 2020 Sep; 25(9):. PubMed ID: 32981239 [TBL] [Abstract][Full Text] [Related]
38. In vivo 19F MR studies of fluorine labeled photosensitizers in a murine tumor model. Ramaprasad S; Ripp E; Missert J; Pandey RK Curr Drug Discov Technol; 2007 Aug; 4(2):126-32. PubMed ID: 17691914 [TBL] [Abstract][Full Text] [Related]
39. In vitro and in vivo antitumor activity of a novel porphyrin-based photosensitizer for photodynamic therapy. Chen JJ; Hong G; Gao LJ; Liu TJ; Cao WJ J Cancer Res Clin Oncol; 2015 Sep; 141(9):1553-61. PubMed ID: 25609073 [TBL] [Abstract][Full Text] [Related]
40. Tumor-secreted vascular permeability factor/vascular endothelial growth factor influences photosensitizer uptake. Roberts WG; Hasan T Cancer Res; 1993 Jan; 53(1):153-7. PubMed ID: 8416739 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]